Stem Cell Therapy for Scleroderma

What is Scleroderma?

Scleroderma is an autoimmune disorder that affects the skin and connective tissues of the body. The condition affects women more frequently than men, and usually occurs between the ages of 30 and 50. The disorder causes an overproduction of collagen, which causes the skin and connective tissues to thicken, harden, and tighten. Scleroderma also causes scarring and inflammation, and may lead to hardening of the blood vessels and organs. Symptoms of scleroderma include red, hardened or thickened patches of the skin, tightened skin that may restrict movement, sores and ulcers of the skin, and skin rashes. Some scleroderma patients also experience swelling and pain in the joints, extreme responses to cold temperatures, digestive disorders such as indigestion and acid reflux, shortness of breath, and extreme fatigue. Scleroderma has no cure, and treatments for the condition target painful symptoms. Current treatments include self-care like moisturizers, and medical care, including steroids and physical therapy. The most severe form of scleroderma is called Progressive Systemic Sclerosis.

How Can Stem Cells Help Scleroderma?

For patients with scleroderma, Innovations Stem Cell Center deploys stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.  Innovations Medical is part of the Cell Surgical Network that has been collecting data on stem cells for scleroderma for several years.  Almost 70% of scleroderma patients see improvement.

Graph od scleroderma response to stem cell therapy

Pulmonary fibrosis is a common complication of scleroderma and stem cells work well for pulmonary fibrosis (click to learn more) as well.  Remember, most of the scleroderma and pulmonary fibrosis patients have tried many other therapies before turning to stem cells.

Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.